glp-1 weight management program eligibility criteria Medicare Just Changed Course on $50 Coverage 🚨 A new Medicare program

GLP-1 medications like semaglutide are not recommended for individuals with a history of: Medullary thyroid carcinoma (or a family history of it) Multiple endocrine neoplasia syndrome type 2 (MEN 2) Pancreatitis or gallbladder disease Severe gastrointestinal disorders FuturHealth clinicians screen all patients for these risk factors during the onboarding process

194 SaupeS

1st ed (2021)

(PubMed) Boeke CE, Gillman MW, Hughes MD, Rifas-Shiman SL, Villamor E, Oken E

instead, it reduces calorie intake by suppressing appetite, creating a calorie deficit through behavioral and physiological appetite suppression rather than metabolic acceleration